Mar 12, 2026 4:01pm EDT Capricor Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update
Mar 12, 2026 9:00am EDT Capricor Therapeutics Announces Late-Breaking HOPE-3 Data at the 2026 MDA Conference Demonstrating Significant Functional Benefits of Deramiocel for Duchenne Muscular Dystrophy
Mar 12, 2026 4:30 pm EDT Capricor Therapeutics Fourth Quarter 2025 Financial Results and Corporate Update Conference Call
Mar 11, 2026 2:45 pm EDT 2026 Muscular Dystrophy Association (MDA) Clinical and Scientific Conference